Related Experiment Video
Updated: Jul 17, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Update on advances in atherothrombosis.
Javier Sanz1, Pedro R Moreno, Valentin Fuster
1Department of Medicine/Cardiology, Mount Sinai School of Medicine, New York, NY 10029, USA.
Recent advances in atherothrombosis research include improved diagnostic imaging, novel biomarkers for risk prediction, and evidence supporting statin therapy. Understanding immunity and neovascularization also offers new insights into disease progression.
Area of Science:
- Cardiovascular Research
- Thrombosis and Hemostasis
- Medical Imaging
Background:
- Atherothrombosis is a complex disease with ongoing research into its various facets.
- Understanding the arterial wall, molecular processes, and disease markers is crucial.
Purpose of the Study:
- To provide an overview of recent advances in atherothrombosis research.
- To highlight key developments in diagnostic imaging, biomarkers, and therapeutics.
- To inform healthcare professionals about the latest findings and research directions.
Main Methods:
- Review of recent studies in diagnostic imaging (MRI, multidetector CT).
- Exploration of molecular imaging techniques for cellular processes.
- Identification and evaluation of novel biomarkers for inflammation, thrombogenicity, and oxidative stress.
- Analysis of therapeutic agents, particularly statins.
- Investigation into the roles of immunity and neovascularization in atherogenesis.
Main Results:
- Diagnostic imaging advances allow detailed evaluation of arterial wall lesions.
- Molecular imaging offers visualization of cellular and molecular disease mechanisms.
- Novel biomarkers aid in predicting early disease and clinical event risk.
- Accumulating evidence supports the efficacy of pharmacologic agents like statins.
- New understanding of immunity and neovascularization impacts atherogenesis insights.
Conclusions:
- Significant progress has been made across diagnostic, molecular, and therapeutic aspects of atherothrombosis.
- Continued research into biomarkers, immunity, and neovascularization is vital.
- Awareness of these advances is essential for clinicians managing patients with atherothrombosis.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
